Please note: AABB reserves the right to make updates to this program.
Tuesday, January 23, 2018
2:00 – 3:00 PM (ET) 7:00 – 8:00 PM (GMT)
Master Program Number: 18EL-309 (see program format numbers below under Registration)
Educational Track: Cellular Therapies
Topic: Quality Education
Intended Audience: Managers/Supervisors, Medical Directors, Nurses, Technologists, CT Assessors
Teaching Level: Intermediate to Advanced
Director: Mónica Freire, BS, Standards Development Manager, ICCBBA, San Bernardino, CA
Moderator: Sarah Dickerson, MT(ASCP), Accreditation Manager, Cellular Therapies, AABB, Bethesda, MD
Speakers: Tami Yonke, MT(ASCP)SBB, Med, Project and Systems Specialist, St. Louis Cord Blood Bank,
SSM Health Cardinal Glennon Children’s Hospital, St. Louis, MO; Liz Smith MT(ASCP)SBB, CQA(ASQ), Former AABB Staff Lead Assessor, Independent Consultant for CT and Quality Systems, Media, PA; Mónica Freire, BS, Standards Development Manager, ICCBBA, San Bernardino, CA
After participating in this educational activity, participants should be able to:
- Identify the minimum information required for CT products labeled with ISBT 128.
- Coordinate the ISBT 128 Standard with the AABB Standards.
- Identify the uses and limitations of the Cellular Therapy (CT) audit tool.
- Assess ISBT 128 compliance using the interactive and/or printable checklists from the CT audit tool.
Is your program compliant with the requirements for ISBT 128 Implementation? What will assessors look for? What sort of validation is expected? A multiorganizational task force has partnered with ICCBBA to develop a tool that each stakeholder organization can use to assess compliance with ISBT 128 Implementation requirements. This e cast will review the tool, its application in the processing facility, and its role in AABB assessments.
Designed for those that use the AABB Standards for Cellular Therapy Services and AABB Assessors alike, this program will allow participants to learn how to use key features of the interactive and printable checklists, maximizing the application of this audit tool. Participants will hear first hand from an assessor for cellular therapy activities and from a facility that has implemented ISBT 128 and used the tool to internally confirm compliance with the standards. As the global standard for the coding and labeling of cellular therapy products, ISBT 128 has gained international acceptance. Currently, facilities in more than 77 countries across six continents are registered to use ISBT 128.
| || ||
|Single Viewer: Live||
|Single Viewer: On-Demand||
|Group Viewing: Live||
|Group Viewing: On-Demand||
|Group Viewing: Live & On-Demand||
Tami Yonke, MT(ASCP)SBB, MEd, has over 25 years of experience in cellular therapy, blood center operations, and transfusion medicine. She has been with the St. Louis Cord Blood Bank – SSM Health Cardinal Glennon Children’s Hospital in St. Louis, MO since 2012 and is currently the Project and Systems Specialist. She implemented ISBT 128 labeling at the St. Louis Cord Blood Bank in 2013. She has multi-level experiences in blood center operations with the Missouri-Illinois Region of the American Red Cross with responsibilities for apheresis collections, manufacturing, donor testing and participation on several National projects. She managed the transfusion service at St. Louis University Hospital, a tertiary care teaching facility.
Liz Smith has more than 25 years’ experience in Blood Banking and Cellular Therapies. She has been an AABB staff lead assessor for the past 13 years. She is retired and consulting part time.
Mónica Freire, BS, has over 16 years of experience in blood component manufacturing and blood center operations. She has been with ICCBBA since 2016 and is currently the Standards Development Manager.